Back to Search Start Over

P84.09 Asian Subgroup Analysis of a Phase II Study Evaluating Lorlatinib Efficacy in Previously Treated ALK-Positive Advanced NSCLC.

Authors :
Soo, R.
Lin, C.
Kim, D.
Seto, T.
Tan, E.
Hayashi, H.
Abbattista, A.
Martini, J.
Wong, C.H.
Toffalorio, F.
Solomon, B.
Source :
Journal of Thoracic Oncology; 2021 Supplement, Vol. 16 Issue 3, pS660-S660, 1p
Publication Year :
2021

Details

Language :
English
ISSN :
15560864
Volume :
16
Issue :
3
Database :
Complementary Index
Journal :
Journal of Thoracic Oncology
Publication Type :
Academic Journal
Accession number :
149366863
Full Text :
https://doi.org/10.1016/j.jtho.2021.01.1208